Yoshihiko Murata

Summary

Affiliation: Rochester General Hospital
Country: USA

Publications

  1. ncbi request reprint Pulmonary complications of interpandemic influenza A in hospitalized adults
    Yoshihiko Murata
    Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Department of Medicine, Rochester General Hospital, Rochester, NY 14621, USA
    J Infect Dis 195:1029-37. 2007
  2. ncbi request reprint Respiratory syncytial virus infection in adults
    Yoshihiko Murata
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester General Hospital, New York, USA
    Antivir Ther 12:659-70. 2007
  3. doi request reprint Respiratory syncytial virus infection in adults
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Infectious Diseases Unit, Rochester General Hospital, Rochester, New York 14621, USA
    Curr Opin Pulm Med 14:235-40. 2008
  4. pmc Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Rochester General Hospital, 601 Elmwood Avenue Box 689, Rochester, NY 14642, USA Yoshihiko
    Vaccine 28:6242-6. 2010
  5. pmc Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 689, Rochester, NY 14642, USA
    Clin Vaccine Immunol 17:695-7. 2010
  6. ncbi request reprint Impact of rapid diagnosis on management of adults hospitalized with influenza
    Ann R Falsey
    Departments of Medicine, Rochester General Hospital and University of Rochester School of Medicine and Dentistry, Rochester, NY 14621, USA
    Arch Intern Med 167:354-60. 2007
  7. pmc Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Vaccine 30:5382-8. 2012
  8. pmc Respiratory syncytial virus vaccine development
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Lab Med 29:725-39. 2009
  9. pmc Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Virol J 6:81. 2009
  10. pmc An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization
    Anna C Jacobs
    Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 9:e85729. 2014

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Pulmonary complications of interpandemic influenza A in hospitalized adults
    Yoshihiko Murata
    Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Department of Medicine, Rochester General Hospital, Rochester, NY 14621, USA
    J Infect Dis 195:1029-37. 2007
    ....
  2. ncbi request reprint Respiratory syncytial virus infection in adults
    Yoshihiko Murata
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester General Hospital, New York, USA
    Antivir Ther 12:659-70. 2007
    ..Vaccines against RSV remain an unachieved goal. Promising new agents that inhibit the virus-cell fusion, cell-cell fusion, or viral gene expression are currently in development...
  3. doi request reprint Respiratory syncytial virus infection in adults
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Infectious Diseases Unit, Rochester General Hospital, Rochester, New York 14621, USA
    Curr Opin Pulm Med 14:235-40. 2008
    ..Respiratory syncytial virus has increasingly been recognized as a clinically significant cause of respiratory tract infections in adults, especially among the elderly and the immunocompromised...
  4. pmc Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Rochester General Hospital, 601 Elmwood Avenue Box 689, Rochester, NY 14642, USA Yoshihiko
    Vaccine 28:6242-6. 2010
    ..Our results have implications for RSV G-based serological diagnostics and vaccine development...
  5. pmc Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 689, Rochester, NY 14642, USA
    Clin Vaccine Immunol 17:695-7. 2010
    ..In approximately 40% of hospitalized and outpatient adults infected with RSV subtype A, these contiguous residues are the target of > or =4-fold increases in IgG response between acute- and convalescent-phase sera...
  6. ncbi request reprint Impact of rapid diagnosis on management of adults hospitalized with influenza
    Ann R Falsey
    Departments of Medicine, Rochester General Hospital and University of Rochester School of Medicine and Dentistry, Rochester, NY 14621, USA
    Arch Intern Med 167:354-60. 2007
    ..We compared the clinical management of patients with influenza whose rapid antigen test result was positive (Ag+) with the management of those whose rapid antigen test result was negative or the test was not performed (Ag0)...
  7. pmc Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Vaccine 30:5382-8. 2012
    ..Our results have implications for RSV G-based serological assays as well as prophylactic immunotherapy and RSV vaccine development...
  8. pmc Respiratory syncytial virus vaccine development
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Clin Lab Med 29:725-39. 2009
    ..The scientific rationale, preclinical testing, and clinical development of each of these approaches are reviewed...
  9. pmc Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres
    Yoshihiko Murata
    Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Virol J 6:81. 2009
    ..We sought to utilize HPV L1 capsomeres as a vaccine platform by engineering heterologous epitopes within L1 derivatives deleted for h4 domain...
  10. pmc An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization
    Anna C Jacobs
    Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America
    PLoS ONE 9:e85729. 2014
    ..Moreover, the enzyme may be an effective target for the intervention of biomaterial colonization, and consequently limit the organism's transmission within the hospital setting. ..